Brief: Diamyd Medical: Promising Topline Results For Intralymphatic Diamyd In Patients With LADA
07/07/2022 14:43
July 7 (Reuters) - Diamyd Medical AB DMYDb.ST :
* PROMISING TOPLINE RESULTS FOR INTRALYMPHATIC DIAMYD® IN PATIENTS WITH LADA
* PRIMARY ENDPOINTS OF SAFETY AND TOLERABILITY WERE MET
* ANALYSES ALSO SHOWED POSITIVE IMMUNOLOGICAL RESPONSE TO TREATMENT
* CLINICAL COURSE APPEARS PROMISING WITH ALL INDIVIDUALS REMAINING INSULIN-INDEPENDENT 12
MONTHS
AFTER TREATMENT
Source text for Eikon: ID:nWkr6K1T7X
Further company coverage: DMYDb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))